模拟禁食饮食富集的假小链双歧杆菌通过诱导记忆CD8+ T细胞抑制结直肠癌
该研究探讨模拟禁食饮食(FMD)经肠道菌群调控抗结直肠癌(CRC)的机制。粪便宏基因组测序显示FMD处理的CRC小鼠中假小链双歧杆菌(Bifidobacterium pseudolongum)富集,该菌通过增加组织驻留记忆CD8+ T细胞(TRM)介导FMD抗肿瘤效应。L-精氨酸为该菌功能代谢物,经SLC7A1受体转运诱导TRM表型;FMD和该菌均改善原位小鼠CRC模型中抗CTLA-4疗效。FMD处理的CRC患者中CD8+ TRM细胞数随该菌和L-精氨酸积累而增加,CD8+ TRM细胞和该菌丰度与更好预后相关。
要点
- FMD处理的CRC小鼠粪便中假小链双歧杆菌富集,该菌介导FMD抗肿瘤效应。
- L-精氨酸为假小链双歧杆菌功能代谢物,经SLC7A1诱导CD8+ T细胞TRM表型。
- FMD和假小链双歧杆菌均改善原位小鼠CRC模型中抗CTLA-4疗效。
核心结论
- 假小链双歧杆菌通过产生L-精氨酸促进CD8+ T细胞分化为记忆细胞,参与FMD抗CRC效应;给予该菌是潜在的CRC治疗策略。
研究设计与样本
- 采用粪便宏基因组测序评估FMD处理的CRC小鼠中益生菌物种富集,并在抗生素处理的常规小鼠和无菌小鼠模型中验证候选物种。
- 利用单细胞RNA测序和多色流式细胞术评估免疫格局变化,通过代谢组学分析鉴定菌群来源抗肿瘤代谢物。
主要发现
- 粪便宏基因组分析显示FMD处理的CRC小鼠中假小链双歧杆菌富集。
- 假小链双歧杆菌通过增加CRC小鼠组织驻留记忆CD8+ T细胞(TRM)群体介导FMD抗肿瘤效应。
- FMD处理的CRC小鼠中假小链双歧杆菌功能代谢物L-精氨酸水平升高,L-精氨酸在体内和体外诱导TRM表型。
- L-精氨酸由CD8+ T细胞中溶质载体家族7成员1(SLC7A1)受体转运。
- FMD和假小链双歧杆菌均改善原位小鼠CRC模型中抗CTLA-4疗效。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Fasting-mimicking diet (FMD) boosts the antitumour immune response in patients with colorectal cancer (CRC). The gut microbiota is a key host immunity regulator, affecting physiological homeostasis and disease pathogenesis. OBJECTIVE: We aimed to investigate how FMD protects against CRC via gut microbiota modulation. DESIGN: We assessed probiotic species enrichment in FMD-treated CRC mice using faecal metagenomic sequencing. The candidate species were verified in antibiotic-treated conventional and germ-free mouse models. Immune landscape alterations were evaluated using single-cell RNA sequencing and multicolour flow cytometry. The microbiota-derived antitumour metabolites were identified using metabolomic profiling. RESULTS: Faecal metagenomic profiling revealed Bifidobacterium pseudolongum enrichment in FMD-treated CRC mice. B. pseudolongum mediates the FMD antitumour effects by increasing the tissue-resident memory CD8+ T-cell (TRM) population in CRC mice. The level of L-arginine, a B. pseudolongum functional metabolite, increased in FMD-treated CRC mice; furthermore, L-arginine induced the TRM phenotype in vivo and in vitro. Mechanistically, L-arginine is transported by the solute carrier family 7-member 1 (SLC7A1) receptor in CD8+ T cells. Both FMD and B. pseudolongum improved anti-CTLA-4 efficacy in the orthotopic mouse CRC model. In FMD-treated patients with CRC, the CD8+ TRM cell number increased as B. pseudolongum and L-arginine accumulated. The abundance of CD8+ TRM cells and B. pseudolongum was associated with a better prognosis in patients with CRC. CONCLUSION: B. pseudolongum contributes to the FMD antitumour effects in CRC by producing L-arginine. This promotes CD8+ T-cell differentiation into memory cells. B. pseudolongum administration is a potential CRC therapeutic strategy.
引用
- Nan K, Zhong Z, Yue Y, et al. Fasting-mimicking diet-enriched Bifidobacterium pseudolongum suppresses colorectal cancer by inducing memory CD8+ T cells. Gut. 2025. PMID: 39870395. doi:10.1136/gutjnl-2024-333020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。